Claybrook Capital’s Varian Medical Systems, Inc. VAR Stock Holding History

Claybrook Capital’s Portfolio VAR Stock Details VAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-114	Closed	-$13K	–	761
2018 Q4	$13K	Buy	+114	New	+$13K	﹤0.01%	433

Other funds holding VAR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Claybrook Capital's VAR Position: Q1 2019 in Review

Claybrook Capital sold out of Varian Medical Systems, Inc. (VAR) in Q1 2019, closing a stake of 114 shares — an estimated $13K sold.

Claybrook Capital first reported a position in VAR in Q4 2018 and held it in 1 quarter. The position peaked at $13K in Q4 2018. 623 funds tracked by Wall St. Rank hold VAR as of Q1 2019.

Claybrook Capital reported no remaining Varian Medical Systems, Inc. position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 114 Varian Medical Systems, Inc. shares in Q1 2019, an estimated $13K.
Claybrook Capital first reported a position in Varian Medical Systems, Inc. in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Varian Medical Systems, Inc. position peaked at $13K in Q4 2018.
623 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.